(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients: Global Markets" report has been added to ResearchAndMarkets.com's offering.
The Active Pharmaceutical Ingredients market was valued at USD 247.8 billion in 2024, and is expected to reach USD 347.9 billion by 2029, rising at a CAGR of 5.90%. In the global pharmaceutical supply chain, APIs act as the building blocks for drug development and manufacturing. The rising demand for specialty drugs and the widespread use of generic medicines is driving this growth. Technological advances in API production, scaling production capacities, the rising incidence of chronic diseases, expanding global healthcare infrastructures and increased investments in drug development are also driving this growth.
Chemical synthesis of APIs is the main method for the production of APIs and acts as a replacement for natural extraction procedures to improve economies of scale. The global market for synthetically manufactured APIs was valued at $181.3 billion in 2023, and this market is expected to achieve a CAGR of 5.4% and reach a value of $246.1 billion by the end of 2029. The importance of biotech production methods is growing due to the rise of biologic drug products made almost exclusively this way. Advances in synthetic biology technologies, such as genetic engineering, metabolic pathway optimization and analytical instrumentation, have further enhanced the efficiency and yield of biotechnology processes, making them more commercially viable. The global market for APIs manufactured through biotech methods was valued at $66.5 billion in 2023, and this market is expected to have a CAGR of 7.4% and reach a value of $101.7 billion by the end of 2029.
The COVID-19 pandemic exposed the risks of over-reliance on specific regions for API production. As a result, there is a trend toward diversifying the supply chain and increasing domestic API manufacturing capabilities in the U.S., Europe, Japan and India to enhance supply chain resilience.
Report Scope
This goal of this report is to impart in-depth knowledge of the global market for active pharmaceutical ingredients (APIs), in terms of both qualitative and quantitative data, to help readers assess the market landscape, develop business/growth strategies, and analyze their market position. The report estimates market size for 2023 (the base year) and forecasts values for 2024 by the end of 2029.
In this report, the API market is analyzed by manufacturer type, production method, molecule type, region and country. Industry growth trends, drivers, restraints and opportunities in the API market are also discussed in detail. The scope of the study is global.
The report includes:
64 data tables and 38 additional tables An analysis of the global markets for active pharmaceutical ingredients (APIs) Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecast for 2025, and projected CAGRs through 2029 Estimates of the size and revenue prospects of the global market, along with a market share analysis by origin, drug molecular entity type, manufacturer type, end use and region Facts and figures pertaining to the market dynamics, technical advances, API sources, production methods, route of synthesis, regulations, and the impact of macroeconomic variables A Porter's Five Forces model, and global supply chain and PESTLE analyses Patent activity featuring issues like patent expiry and its impact on the pharmaceutical market, and details of changes in pharmaceutical drug development Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity and a venture funding outlook Company profiles of major players within the Active Pharmaceutical Ingredients Market, including Pfizer, Thermo Fisher Scientific Inc., EuroAPI, Lonza, Siegfried Holding and Divi's Laboratories Ltd.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 119 |
| Forecast Period | 2024 - 2029 |
| Estimated Market Value (USD) in 2024 | $247.8 Billion |
| Forecasted Market Value (USD) by 2029 | $347.9 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Market Overview
APIs Defined Global API Supply Chain API Production Methods API Production: Route of Synthesis Production Methods
Chapter 3 Market Dynamics
Market Drivers Resilient Pharmaceutical Demand Increase in Adoption of Generics Shift to More Complex Chemical Entities Growth in the Biologics Market Advances in API Manufacturing Government Support
Market Restraints Strict Regulations and Compliance Requirements Pricing Pressure in the Generic API Industry Shortage of Skilled Professionals
Market Trends Increasing Demand for Complex APIs Regional Diversification and Supply Chain Resilience Continuous Flow Manufacturing Expansion of Single-Use Technologies Growing Sustainability Practices in API Manufacturing Increased Outsourcing and CDMO Partnerships
Chapter 4 Emerging Technologies and Developments
Biocatalysis for Complex Synthetic API Manufacturing Integration of AI and ML Flexible Manufacturing
Chapter 5 Market Segmentation Analysis
API Market, by Manufacturer Type Captive and Contract Manufacturing Market Merchant Market API Market, by Production Method Chemical Synthesis Biotech
API Market, by Molecule Type Small-Molecule APIs Large Molecule
Geographic Breakdown
Chapter 6 Competitive Intelligence
Supplier Landscape Captive Manufacturers Contract Manufacturers Merchant Manufacturers Generic API Market Landscape Innovative API Market Landscape Porter's Five Forces Analysis
Company Profiles
Aurobindo Pharma Divi's Laboratories Ltd. Euroapi Evonik Industries AG Lonza Pfizer Inc. Siegfried Holding AG Teva Pharmaceutical Industries Ltd. Thermo Fisher Scientific Inc. Wuxi Apptec
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Active Pharmaceutical Ingredients Market
CONTACT: CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
MENAFN01112024004107003653ID1108841035
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.